N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Struktur
1628530-41-5
CAS-Nr.
1628530-41-5
Englisch Name:
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide
Synonyma:
Cabozantinib impurity 66;Cabozantinib Impurity 79;Tributyl Acetylcitrate Impurity 2 (Tributyl Acetylcitrate EP Impurity B);N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity)
CBNumber:
CB25590036
Summenformel:
C28H24FN3O6
Molgewicht:
517.51
MOL-Datei:
1628530-41-5.mol

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Eigenschaften

Siedepunkt:
788.4±60.0 °C(Predicted)
Dichte
1.447±0.06 g/cm3(Predicted)
pka
8.31±0.10(Predicted)

Sicherheit

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jilin Chinese Academy of Sciences-yanshen Technology
+undefined18143011203
info@chemextension.com China 42057 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8043 55
Zhaoqing Wanwei New Material Technology Co., Ltd. 0755-1328880-4488 13068786899
13288804488@163.com China 625 58
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Shenzhen ruikai de biotechnology co., ltd. 0755-61348847 17820674378
2682116078@qq.com China 7844 58
Wuhan chuanghao Biotechnology Co., Ltd 13361917963
876725023@qq.com China 296 58
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd 0755-22677922 18126518403
2851922760@qq.com China 5043 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18865 58
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 63720 58

  • N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide
  • Cabozantinib impurity 66
  • 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-
  • N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide
  • Cabozantinib Impurity 79
  • Tributyl Acetylcitrate Impurity 2 (Tributyl Acetylcitrate EP Impurity B)
  • N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity)
  • 1628530-41-5
Copyright 2019 © ChemicalBook. All rights reserved